| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.00011 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 3.7e-05 | 1 |